Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Earning passive income as a student can help you build wealth without constant effort. Explore these opportunities to get started.
13,937 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
May home sales fell again, highlighting an ongoing affordability squeeze as mortgage costs remain elevated. The data ...
JPMORGAN Global Research says the AI-related capital spend is not a fleeting hype cycle but a profitable buildout. Th...
A viral duck became the centerpiece of a commercial shoot outside Azteca Stadium, but FIFA rules prevented him from s...
A brutal European summer is forcing households to grapple with bigger energy bills and rising health costs as heat wa...
Is Lilly stock undervalued healthcare? This article breaks down the valuation case, growth catalysts, risks, and a pr...
A 71-year-old stroke survivor hit the in-network out-of-pocket maximum of a zero-premium Medicare Advantage plan, und...
More Americans 65+ continue to work and fund HSAs, but Medicare Part A backdating can create excess contributions and...
Broadcom just unveiled a chip aimed at speeding AI inference. Could this chip game shift the trajectory for AVGO stoc...
Lawmakers pivot from buyer subsidies to boosting the nation’s housing stock. The road housing bill’s biggest breakthr...
A new Ipsos poll reveals growing World Cup enthusiasm among U.S. fans while broad adoption lags. The findings hint at...
A Northeast bank insider sold 12,190 shares for about $817k, signaling more than a single move. Learn what it could m...